(Press-News.org) Irvine, Calif., April 16, 2014 — A class of drugs developed to treat immune-related conditions and cancer – including one currently in clinical trials for glioblastoma and other tumors – eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to UC Irvine researchers.
In their study, assistant professor of neurobiology & behavior Kim Green and colleagues discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
"Because microglia are implicated in most brain disorders, we feel we've found a novel and broadly applicable therapeutic approach," Green said. "This study presents a new way to not just modulate inflammation in the brain but eliminate it completely, making this a breakthrough option for a range of neuroinflammatory diseases."
The researchers focused on the impact of a class of drugs called CSF1R inhibitors on microglial function. In mouse models, they learned that inhibition led to the removal of virtually all microglia from the adult central nervous system with no ill effects or deficits in behavior or cognition. Because these cells contribute to most brain diseases – and can harm or kill neurons – the ability to eradicate them is a powerful advance in the treatment of neuroinflammation-linked disorders.
Green said his group tested several selective CSF1R inhibitors that are under investigation as cancer treatments and immune system modulators. Of these compounds, they found the most effective to be a drug called PLX3397, created by Plexxikon Inc., a Berkeley, Calif.-based biotechnology company and member of the Daiichi Sankyo Group. PLX3397 is currently being evaluated in phase one and two clinical trials for multiple cancers, including glioblastoma, melanoma, breast cancer and leukemia.
Crucially, microglial elimination lasted only as long as treatment continued. Withdrawal of inhibitors produced a rapid repopulation of cells that then grew into new microglia, said Green, who's a member of UC Irvine's Institute for Memory Impairments and Neurological Disorders.
This means that eradication of these immune cells is fully reversible, allowing researchers to bring microglia back when desired. Green added that this work is the first to describe a new progenitor/potential stem cell in the central nervous system outside of neurogenesis, a discovery that points to novel opportunities for manipulating microglial populations during disease.
INFORMATION:
Study results appear in today's issue of Neuron. Monica Elmore, Allison Najafi, Maya Koike, Nabil Dagher, Elizabeth Spangenberg and Rachel Rice of UC Irvine; Bernice Matusow, Hoa Nguyen and Brian West of Plexxikon Inc.; and Masashi Kitazawa of UC Merced contributed to the research, which received support from the National Institute of Neurological Disorders & Stroke (grants 1R01NS083801 and F31NS086409).
About the University of California, Irvine: Located in coastal Orange County, near a thriving employment hub in one of the nation's safest cities, UC Irvine was founded in 1965. One of only 62 members of the Association of American Universities, it's ranked first among U.S. universities under 50 years old by the London-based Times Higher Education. The campus has produced three Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Michael Drake since 2005, UC Irvine has more than 28,000 students and offers 192 degree programs. It's Orange County's second-largest employer, contributing $4.3 billion annually to the local economy.
Media access: UC Irvine maintains an online directory of faculty available as experts to the media at today.uci.edu/resources/experts.php. Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UC Irvine faculty and experts, subject to availability and university approval. For more UC Irvine news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.
NOTE TO EDITORS: Photo available at:
http://news.uci.edu/press-releases/cancer-drugs-block-dementia-linked-brain-inflammation-uci-study-finds/
Cancer drugs block dementia-linked brain inflammation, UCI study finds
Research represents novel approach to lessening impact of Alzheimer's, Parkinson's
2014-04-16
ELSE PRESS RELEASES FROM THIS DATE:
Recycling industrial waste water
2014-04-16
A research group composed of Dr. Martin Prechtl, Leo Heim and their colleagues at the University of Cologne's Department of Chemistry has discovered a new method of generating hydrogen using water and formaldehyde. The generation of hydrogen from liquids is of particular interest when it comes to fuel cell technologies. The results of the project, entitled "Selective and mild hydrogen production using water and formaldehyde", have recently been published in the journal Nature Communications.
Among other applications, the new approach can be used to recycle industrial ...
Research uncovers DNA looping damage tied to HPV cancer
2014-04-16
It's long been known that certain strains of human papillomavirus (HPV) cause cancer. Now, researchers at The Ohio State University have determined a new way that HPV might spark cancer development – by disrupting the human DNA sequence with repeating loops when the virus is inserted into host-cell DNA as it replicates.
Worldwide, HPV causes about 610,000 cases of cancer annually, accounting for about five percent of all cancer cases and virtually all cases of cervical cancer. Yet, the mechanisms behind the process aren't yet completely understood.
This study, recently ...
New type of barcode could make counterfeiters' lives more difficult
2014-04-16
Counterfeiters, beware! Scientists are reporting the development of a new type of inexpensive barcode that, when added to documents or currency, could foil attempts at making forgeries. Although the tags are easy for researchers to make, they still require ingredients you can't exactly find at the local hardware store. Their report appears in the Journal of the American Chemical Society.
Xiaogang Liu and colleagues explain that scientists have used fluorescent and DNA-based barcodes, or tags of known composition and sequence, in attempts to develop tests for cancer and ...
A greener source of polyester -- cork trees
2014-04-16
On the scale of earth-friendly materials, you'd be hard pressed to find two that are farther apart than polyester (not at all) and cork (very). In an unexpected twist, however, scientists are figuring out how to extract a natural, waterproof, antibacterial version of the first material from the latter. Their new technique, which could have applications in medical devices, appears in the ACS journal Biomacromolecules.
Cristina Silva Pereira and colleagues explain that polyesters are ubiquitous in modern life, and not just as a practical fabric for clothing. Their durability ...
Local homicide rate increases cause more elementary students to fail school
2014-04-16
WASHINGTON, DC, April 16, 2014 — A new study finds that an increase in a municipality's homicide rate causes more elementary school students in that community to fail a grade than would do so if the rate remained stable.
"This finding is a source of concern because exposure to environmental violence is highly prevalent in contemporary societies and is unequally distributed along socioeconomic lines," said study co-author Florencia Torche, an associate professor of sociology at New York University. "To the extent that children living in poverty are more likely to experience ...
Making radiation-proof materials for electronics, power plants
2014-04-16
The 2011 Fukushima nuclear disaster made the dangers of radiation all too real. To avoid similar tragedies in the future, scientists are working to develop new radiation-proof materials for nuclear power plants, as well as for less obvious applications such as medical devices and airplanes. An article in Chemical & Engineering News (C&EN), the American Chemical Society's weekly news magazine, explores the latest developments.
Jyllian Kemsley, a senior editor at C&EN, points out that radiation can cause a range of problems from temperature misreadings in electronic devices ...
U of T study finds toddlers 'surprisingly sophisticated' at understanding unfamiliar accents
2014-04-16
TORONTO, ON -- A new University of Toronto study has found that by two years of age, children are remarkably good at comprehending speakers who talk with accents the toddlers have never heard before.
Even more striking, say researchers, children as young as 15 months who have difficulty comprehending accents they've never heard before can quickly learn to understand accented speech after hearing the speaker for a short time.
"Fifteen-month-olds typically say relatively few words, yet they can learn to understand someone with a completely unfamiliar accent," says Elizabeth ...
Survey: Percent of uninsured Texans has declined since September 2013
2014-04-16
HOUSTON – (April 16, 2014) – The percentage of uninsured adults ages 18 to 64 in Texas declined from 24.8 to 23.5 between September 2013 and March 2014, according to a report released today by Rice University's Baker Institute for Public Policy and the Episcopal Health Foundation. The decrease in uninsured appears to be attributable to an increase in employer-sponsored health insurance.
The report also found that during this period approximately 746,000 Texans purchased health insurance through the Affordable Care Act's Health Insurance Marketplace, of which 178,000 ...
HIV+ women respond well to HPV vaccine
2014-04-16
PROVIDENCE, R.I. [Brown University] — HIV-positive women respond well to a vaccine against the human papillomavirus (HPV), even when their immune system is struggling, according to newly published results of an international clinical trial. The study's findings counter doubts about whether the vaccine would be helpful, said the Brown University medical professor who led the study. Instead, the data support the World Health Organization's recommendation to vaccinate women with HIV.
HPV causes cervical and other cancers. The commonly used HPV vaccine Gardasil had not been ...
First metritis vaccine protects dairy cows
2014-04-16
ITHACA, N.Y. – Cornell scientists have created the first vaccines that can prevent metritis, one of the most common cattle diseases. The infection not only harms animals and farmers' profits, but also drives more systemic antibiotic use on dairy farms than any other disease.
The new vaccines prevent metritis infection of the uterus from taking hold and reduce symptoms when it does, a prospect that could save the United States billions of dollars a year and help curb the growing epidemic of antibiotic resistance. The research was published in the journal PLOS One.
Metritis ...
LAST 30 PRESS RELEASES:
University of Cincinnati experts present research at annual hematology event
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
Dose of psilocybin, dash of rabies point to treatment for depression
Helping health care providers navigate social, political, and legal barriers to patient care
Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments
Using smartphones to improve disaster search and rescue
Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing
Ultrafast material captures toxic PFAS at record speed and capacity
Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli
UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections
OYE Therapeutics closes $5M convertible note round, advancing toward clinical development
Membrane ‘neighborhood’ helps transporter protein regulate cell signaling
Naval aviator turned NPS doctoral student earns national recognition for applied quantum research
[Press-News.org] Cancer drugs block dementia-linked brain inflammation, UCI study findsResearch represents novel approach to lessening impact of Alzheimer's, Parkinson's
